Daré Bioscience, Inc. (NASDAQ: DARE), a purpose-driven health biotech company solely focused on closing the gap in women’s health between promising science and real-world solutions, today announced ...

Regencell Bioscience (RGC)  is up ~35% on much higher than usual volume in what appears to be a short squeeze situation. As ...

South Korea's Penetrium Bioscience said Wednesday that the company would start a clinical test combining its investigational ...

SK bioscience said Thursday it will lead an artificial intelligence (AI) project funded by the Gates Foundation aimed at ...

First consumer health product positions Daré for revenue generation while expanding its women's health leadership platformAccess the segment ...

SK Bioscience is partnering with the Bill & Melinda Gates Foundation to shift the paradigm of vaccine development through ...

SK bioscience secures UNICEF flu vaccine deal, expands global procurement unicef taps SK bioscience to deliver SkyCellflu ...

Osterweis Capital Management, an investment management firm, released its Q1 2026 investor update for its “Osterweis ...

Niagen Bioscience is back in focus after analysts cut their combined price targets by US$5 while still holding the fair value ...

Company receives grant from the Gates Foundation to develop srRNA vaccine candidates for tuberculosis, subject to humanitarian licensing terms SAN DIEGO /PRNewswire/ -- Replicate Bioscience, a ...

Margaret R. McLean delivered this address to the Keck Graduate Institute Convocation in September 2010. She is associate director of the Markkula Center for Applied Ethics and Director of Bioethics.

Members of the Albuquerque Regional Economic Alliance and other state organizations will attend the conference June 22-25.